[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Singular Genomics Systems Inc (OMIC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	09-2020	06-2020	03-2020	12-2019
Cash Flows From Operating Activities
Net Income	-27,945	-20,033	-12,100	-5,253	-12,324
Depreciation Amortization	956	672	421	183	340
Accounts payable and accrued liabilities	-148	-5	-69	128	N/A
Other Working Capital	858	655	-42	122	415
Other Operating Activity	1,406	824	568	111	170
Operating Cash Flow	$-24,873	$-17,887	$-11,222	$-4,709	$-11,399

Cash Flows From Investing Activities
Change In Deposits	25,385	17,493	10,222	2,657	N/A
PPE Investments	-1,380	-1,143	-419	-261	-800
Other Investing Activity	0	0	0	0	-30,700
Investing Cash Flow	$24,005	$16,350	$9,803	$2,396	$-31,500

Cash Flows From Financing Activities
Debt Issued	7,500	7,500	7,500	7,500	N/A
Common Stock Issued	45	17	10	10	N/A
Other Financing Activity	-30	-30	0	0	47,304
Financing Cash Flow	$7,515	$7,487	$7,510	$7,510	$47,304

Beginning Cash Position	5,523	5,523	5,523	5,523	1,118
End Cash Position	12,170	11,473	11,614	10,720	5,523
Net Cash Flow	$6,647	$5,950	$6,091	$5,197	$4,405

Free Cash Flow
Operating Cash Flow	-24,873	-17,887	-11,222	-4,709	-11,399
Capital Expenditure	-1,380	-1,143	-419	-261	N/A
Free Cash Flow	-26,253	-19,030	-11,641	-4,970	-11,399